Home | Welcome to Contract Pharma   
Last Updated Thursday, June 20 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

December 13, 2012
Will use GPEx technology to produce cell lines   Read More »
December 13, 2012
To develop treatments for neurological diseases   Read More »
December 7, 2012
Will serve as exclusive commercial supplier for U.S. market   Read More »
December 6, 2012
Will supply ABA product from Rensselaer facility   Read More »
December 6, 2012
Will identify antibodies using ProMIS technology   Read More »
December 5, 2012
Discovery milestone triggers payment   Read More »
December 3, 2012
To use Transcend technology for drug delivery to the brain   Read More »
December 3, 2012
Will use OmniRat platform to generate human antibodies   Read More »
November 30, 2012
Will work to include jet injectors as delivery method for Afluria label   Read More »
November 30, 2012
To develop nanotherapeutics targeting cancers and eye diseases   Read More »
November 29, 2012
To develop a commercial process for flu vaccine production   Read More »
November 28, 2012
Aims to expand applications for high-performance LC-MS systems   Read More »
November 28, 2012
Aims to overcome poor bioavailability   Read More »
November 28, 2012
Will validate assays to support clinical trials   Read More »
November 28, 2012
Will leverage Selecta’s SVP platform for allergy indications   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On